BioSpace News Archive

Veterinary professionals from around the world will convene at VMX 2021, June 5-9 live at the Orange County Convention Center in Orlando and everywhere virtually, to learn the latest in diagnosis, treatment and specialized procedures in animal medicine.

The European Commission (EC) has approved mAbxience’s MB02 biosimilar to Avastin® (Bevacizumab), in Europe.

The Linux Foundation, the nonprofit organization enabling mass innovation through open source, and the OpenTreatments Foundation, which enables treatments for rare genetic diseases regardless of rarity and geography, today announced the RareCamp software project will be hosted at the Linux Foundation

Kronos Bio, Inc. (Nasdaq: KRON) today commented on the passing of John C. Martin, Ph.D., board member and early investor in the company.

The global knee cartilage repair market was valued at approximately US$ 4.0 Bn in 2017.

TMR’s report on the global respiratory monitoring devices market studies past as well as current growth trends and opportunities to gain valuable insights for the said market during the forecast period i.e.

Transparency Market Research has published a new report titled, “Ultrasound Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces the participation of members of the company’s senior management team in four investor and R&D conferences being held virtually during April 2021.

BioInvent International AB announced that the company’s total number of shares as per March 31, 2021 amounts to 58,471,096 shares, corresponding to an equal number of votes.

Rentschler Biopharma SE, a leading global contract development and manufacturing organization for biopharmaceuticals, announced the appointment of Dr. Martin Kessler as Chief Executive Officer of Rentschler Biopharma Inc., the Company’s wholly owned U.S. subsidiary, and as Senior Vice President Transformation of Rentschler Biopharma SE, effective March 1, 2021.